Sign Up Today and Learn More About R3 Vascular Stock
Invest in or calculate the value of your shares in R3 Vascular or other pre-IPO companies through EquityZen's platform.
R3 Vascular Stock (RTHV)
R3 Vascular is a medical device company that develops new therapies to treat peripheral artery disease.
About R3 Vascular Stock
Founded
2019
Headquarters
Mountain View, CA, US
Industries
Software, Data and Analytics, Artificial Intelligence
R3 Vascular Press Mentions
Stay in the know about the latest news on R3 Vascular
R3 Vascular Gains New Funding and New CEO
mpo-mag • Jul 15, 2024
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new President and CEO
static1 • Jul 15, 2024
R3 Vascular Appoints Josh Smale as its Vice President of Global Clinical and Scientific Affairs
globenewswire • Jul 09, 2024
R3 racks up $87M for trials for dissolving stent to treat chronic limb-threatening ischemia
axios • Jun 25, 2024
R3 Vascular Raises $87M in Series B Financing
finsmes • Jun 25, 2024
R3 Vascular Management
Leadership team at R3 Vascular
Board Member
Michael Hurley
Board Member
David Neustaedter
Join now and verify your accreditation status to gain access to:
- R3 Vascular current valuation
- R3 Vascular stock price
- Available deals in R3 Vascular and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in R3 Vascular stock?
Accredited investors can buy pre-IPO stock in companies like R3 Vascular through EquityZen funds. These investments are made available by existing R3 Vascular shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell R3 Vascular stock?
Shareholders can sell their R3 Vascular stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
